ANI PHARMACEUTICALS INC (ANIP)
Data as of , from SEC Form 4 filings.
See up to 3 months of ANIP. The 7-day demo opens the 1M and 3M ranges and puts ANIP on your watchlist.
Start 7-day demoLatest ANIP insider trades
- Meredith Cook - OfficerOpen-market sale$37K
About ANI PHARMACEUTICALS INC (ANIP)
ANI PHARMACEUTICALS INC is an SEC registrant, filing under CIK 0001023024, classified as pharmaceutical preparations. It is grouped with Health Care companies on this site.
ANIP Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 10 | 25,012 | $1.86M |
| Grant or award | 1 | 6,662 | |
| Tax withholding / forfeiture | 1 | 2,466 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
ANIP insider transactions (Form 4)
36114 Form 4 filings on record, the earliest from Oct 15, 2024, newest first. Filing history page 1 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Meredith Cook - Officer | Open-market sale | Common Stock | 500 | $73.59 | $37K | |
| Stephen P. Carey - Officer | Open-market sale | Common Stock | 2,850 | $73.00 footnote F2 | $208K | |
| ||||||
| Nikhil Lalwani - Officer | Open-market sale | Common Stock | 5,400 | $71.00 | $383K | |
 Jeanne Thoma - Director | Open-market sale | Common Stock | 1,000 | $71.53 | $72K | |
| Meredith Cook - Officer | Open-market sale | Common Stock | 500 | $70.79 | $35K | |
| Stephen P. Carey - Officer | Open-market sale | Common Stock | 2,850 | $72.80 footnote F2 | $207K | |
| ||||||
| Henry O. Gosebruch - Director | Grant or award | Common Stock | 6,662 | $0.00 | - | |
| Nikhil Lalwani - Officer | Open-market sale | Common Stock | 5,400 | $74.30 footnote F2 | $401K | |
| ||||||
| Meredith Cook - Officer | Open-market sale | Common Stock | 500 | $75.48 | $38K | |
| Ori Gutwerg - Officer | Open-market sale | Common Stock | 3,162 | $77.00 | $243K | |
| Stephen P. Carey - Officer | Open-market sale | Common Stock | 2,850 | $81.36 footnote F2 | $232K | |
| ||||||
| Meredith Cook - Officer | Tax withholding / forfeiture | Common Stock | 2,466 | $79.20 | $195K | |
| Meredith Cook - Officer | Open-market sale | Common Stock | 500 | $81.84 | $41K | |
| Stephen P. Carey - Officer | Option exercise | Common Stock | 3,313 | $49.51 | $164K | |
| Stephen P. Carey - Officer | Open-market sale | Common Stock | 3,313 | $86.00 | $285K | |
| Stephen P. Carey - Officer | Option exercise | Stock Option (right to buy) | 3,313 | $49.51 | $164K | |
| Stephen P. Carey - Officer | Open-market sale | Common Stock | 2,850 | $84.12 footnote F2 | $240K | |
| ||||||
| Meredith Cook - Officer | Open-market sale | Common Stock | 500 | $82.03 | $41K | |
| Jeanne Thoma - Director | Grant or award | Common Stock | 4,357 | $0.00 | - | |
| Renee P. Tannenbaum - Director | Grant or award | Common Stock | 4,357 | $0.00 | - | |
| Antonio R. Pera - Director | Grant or award | Common Stock | 4,357 | $0.00 | - | |
| Matthew J. Leonard - Director | Grant or award | Common Stock | 4,357 | $0.00 | - | |
| Thomas Haughey - Director | Grant or award | Common Stock | 4,357 | $0.00 | - | |
| Thomas Haughey - Director | Open-market sale | Common Stock | 2,000 | $80.88 | $162K | |
| Stephen P. Carey - Officer | Option exercise | Common Stock | 3,312 | $49.51 | $164K | |
| Stephen P. Carey - Officer | Open-market sale | Common Stock | 3,312 | $80.00 | $265K | |
| Stephen P. Carey - Officer | Option exercise | Stock Option (right to buy) | 3,312 | $49.51 | $164K | |
 Patrick D. Walsh - Director | Open-market sale | Common Stock | 3,973 | $80.75 | $321K | |
| Patrick D. Walsh - Director | Open-market sale | Common Stock | 10,000 | $80.63 | $806K | |
| Thomas Andrew Rowland - Officer | Open-market sale | Common Stock | 459 | $79.21 | $36K | |
| Nikhil Lalwani - Officer | Open-market sale | Common Stock | 55,000 | $77.57 footnote F1 | $4.27M | |
| ||||||
| Ori Gutwerg - Officer | Open-market sale | Common Stock | 2,772 | $79.50 | $220K | |
| Meredith Cook - Officer | Open-market sale | Common Stock | 500 | $78.16 | $39K | |
| Meredith Cook - Officer | Open-market sale | Common Stock | 500 | $77.95 | $39K | |
| Thomas Andrew Rowland - Officer | Open-market sale | Common Stock | 4,772 | $74.91 | $357K | |
| Christopher Mutz - Officer | Open-market sale | Common Stock | 3,162 | $71.64 footnote F2 | $227K | |
| ||||||
Recent ANIP Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| NIKHIL LALWANI | Director, Officer | 5,400 | $380K | View on EDGAR | |
| JEANNE THOMA | Director | 1,000 |
ANIP insider trading FAQ
What is the latest insider trade for ANIP?
ANI PHARMACEUTICALS INC (ANIP) had 12 insider filings in the last 90 days, with the most recent on 2026-10-14. The full record for ANIP runs to 114 Form 4 filings, the earliest from 2024-10-15. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying ANIP stock?
No insider purchases of ANIP were filed in the last 90 days.
How many insiders are selling ANIP stock?
10 insider sales of ANIP were filed in the last 90 days, totaling $1.86M.
Where can I see ANIP SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects ANIP Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Meredith Cook view on EDGAR
- - Stephen P. Carey view on EDGAR
- - Nikhil Lalwani view on EDGAR
- - Jeanne Thoma view on EDGAR
- - Meredith Cook view on EDGAR
- - Stephen P. Carey view on EDGAR
- - Henry O. Gosebruch view on EDGAR
- - Nikhil Lalwani view on EDGAR
- - Meredith Cook view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where ANIP's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow ANIP with a 7-day demo
- ANIP on your watchlist
- Every ANIP Form 4 filing on record
- Up to 3 months of ANIP price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
